Emerging immunologic biomarkers: setting the (TNM-immune) stage.
نویسنده
چکیده
The cooperation of tumor-infiltrating lymphocytes and tertiary lymphoid tissue in early-stage colorectal carcinoma further corroborates the strong immune influences on tumor progression and patient outcome. Immune factors in the tumor microenvironment may warrant inclusion in pathology reports and staging systems for prognostication and prediction of therapeutic response.
منابع مشابه
Biomarkers immune monitoring technology primer: Immunoscore® Colon
Abbreviations: CC, Colon cancer; CRC, Colorectal cancer; CT, Core of the tumor; DAB, Diaminobenzidine; DFS, Disease-free-survival; DP, Digital pathology; DSS, Disease-specific-survival; FFPE, Formalin-fixed paraffin-embedded; IHC, Immunohistochemistry; IM, Invasive margin; INSERM, Institut national de la santé et de la recherche médicale; IS, Immunoscore; IVD, In vitro diagnostic; MSI, Microsat...
متن کاملImmune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.
Although remission rates for metastatic melanoma are generally very poor, some patients can survive for prolonged periods following metastasis. We used gene expression profiling, mitotic index (MI), and quantification of tumor infiltrating leukocytes (TILs) and CD3+ cells in metastatic lesions to search for a molecular basis for this observation and to develop improved methods for predicting pa...
متن کاملPreamble to the 2015 SITC immunotherapy biomarkers taskforce
The Society for Immunotherapy of Cancer (SITC) has regularly hosted workshops and working groups focused on immunologic monitoring and immune biomarkers. Due to advances in cancer immunotherapy, including positive results from clinical trials testing new agents and combinations, emerging new technologies for measuring aspects of immunity, and novel candidate biomarkers from early phase trials, ...
متن کاملThe Tumor-immune Index is Correlated With the Prognosis of Patients After Curative Resection ell Lung Can for Nonsmall C
We developed a novel tumor-immune index (TII) based on carcinoembryonic antigen levels, lymphocyte counts, and platelet counts, and explored its prognostic value in nonsmall cell lung cancer (NSCLC). The prognostic value of the TII was evaluated based on a retrospective study of 205 patients with early NSCLC, who underwent resection in the whole year of 2006, and validated in another group of 2...
متن کاملThe use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection
Head and neck (H&N) cancer is an aggressive disease and the incidence has increased in younger population worldwide. Tumour TNM staging is the main basis for treatment decision despite significant variation in clinical outcome. Survival time of these patients has marginally improved during the last 30 years. Various biomarkers with cumbersome analysis, high cost, time consumption and requiremen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical cancer research : an official journal of the American Association for Cancer Research
دوره 20 8 شماره
صفحات -
تاریخ انتشار 2014